(no text — see the shared post below)
We will finally see a large long-running randomized controlled trial that directly tests alcohol (red wine) verses cardiovascular disease.
The study will run for 5 years, and also report on secondary endpoints of cancer and all-cause mortality.
They are testing alcohol in this trial as if it were a medication. One group will be randomized to consume a set dose of wine each day, and the other group will be randomized to consume an alcohol-free alternative. Everything else will be the same between the two groups. Wine is the only variable.
The trial will be run in the same style as the famous PREDIMED trial that tested a traditional Mediterranean diet vs CVD. In fact, it will be run by the same principle investigator as PREDIMED.
Given the people involved, this should be a very high quality trial.
It will finally give us the truth on mild-to-moderate alcohol consumption and health, whatever that may be.
Quoted:
“Randomized controlled trials are needed to ensure that potential benefits or harms from alcohol consumption are adequately assessed, Martínez-González said. He and his colleagues at the University of Navarra received funding for such a study earlier this year. The study is recruiting physicians ages 50 to 75, who will be randomized to moderate drinking or abstention groups. Both groups will receive free beverages—red wine or an alcohol-free alternative—during the five-year study.”
“So, should we remove wine from the Mediterranean diet?” he asked. “Yes, definitely for those under 35 years.” But for older adults, it’s more complicated. He and his colleagues, and other researchers, have found that the Mediterranean diet loses up to 23.5% of its protective effect if wine is removed.”
Note:
The PREDIMED trial previously showed that a traditional Mediterranean diet including red wine lowered the risk of cardiovascular disease by 30%, as compared to a AHA-style diet that did not include alcohol. This was in healthy people who had never had a heart attack before the start of the trial, i.e. it was a primary prevention trial.
The people who consumed the most red wine in this trial (while not exceeding moderate levels) had 50% less risk of having a heart attack or stroke than the people who consumed the least. The researchers tracked wine consumption with a urinary biomarker that is unique to wine (tartaric acid). This is the most accurate way of tracking alcohol consumption ever used in a long term study to date: ↪ PREDIMED follow-up: urinary tartaric acid links mild-moderate wine to HR 0.5 for CVD.
#alcoholHD #wineHD #predimedHD